Table of Contents 1) Introduction page 3 2) History/Overview of the Industry page 3 3) Economic Characteristics page 4 a) Structure b) Costs c) Demand d) Competition- The Rise of the Generics e) Market Failure, Government Intervention and Price 4) Performance page 7 5) Impact of the Global Economic Downturn page 9 6) Summary page 10 7) Conclusion page 11 Bibliography page 12
Words: 2796 - Pages: 12
on the Bulgarian Stock exchange. 2. Environment a. GDP, inflation, exchange rate, current account deficit b. Products and Markets Sopharma is currently active in three areas: • production of pharmaceuticals, including medicines, mainly generics, and phyto-based substances, nutrition and food supplements (“Production of Pharmaceuticals”), which is primarily carried out by the company and, to a lesser extent, by its production subsidiaries, including Bulgarian Rose Sevtopolis and Unipharma
Words: 7368 - Pages: 30
Indian Pharma Industry – an overview April 13, 2012 The demand for pharmaceutical products in India is significant and is driven by low drug penetration, rising middle-class & disposable income, increased government & private spending on healthcare infrastructure, increasing medical insurance penetration etc. The Indian pharmaceutical industry is growing at about 8 to 9 percent annually according to “A Brief Report Pharmaceutical Industry in India,” published in January 2011. The Pharmaceutical
Words: 1969 - Pages: 8
Johnson & Johnson: Successfully Strategizing for the Changing Global Business Environment April 27, 2009 IBE – D Kara Findley Emily Manz Alex Thompson I. Introduction Johnson & Johnson is the world's largest healthcare company. Founded in the United States in 1886, the company has been profitable for 75 straight years and currently operates 250 subsidiary companies in 57 countries. Its products fall into three segments: pharmaceuticals
Words: 4303 - Pages: 18
|Share Data: | | |Price (11/28/08): $34.15 |P/E (11/28/08): 14.9 | |Shares Outstanding: 1.137B |Forward P/E (2009): 8.85 | |Market Capitalization: 38.82B
Words: 8055 - Pages: 33
trade agreements. * Deregulation of market to allow foreign drugs to compete. Social * Ageing population puts pressure on healthcare systems. * Epidemic of chronic diseases. * Rising consumer expectations. * Payers choosing generic drugs for first-line treatment of common ailments. Technological * Increase productivity, decrease costs and develop new treatment modalities to enhance profitability. * Impact of Internet on traditional business models. * Impact of genetic
Words: 1594 - Pages: 7
over other businesses. Example 1 Why would the drug maker want to stymie generic competition? Explain. There is one major reason that any pharmaceutical company would attempt to stymie generic competition of any loss of their revenues’. Generic brands of drugs are normally provides the exact same level of benefits just at a much lower cost. The drug makers would defiantly lose millions of dollars by allowing a generic copy of their drug to be sold. The second reason would be the cost of
Words: 1015 - Pages: 5
Q1. Identify the main environment forces currently affecting the pharmaceutical industry. PESTLE analysis is used to help the organization to understand what is the current status of the organization and the external factors that are affecting it, whereas this also helps the management of the organizations to overcome the weak areas organizations by implementing the strategy for the future. Political The policies of the government had a great effect on the regulations and legal issues that
Words: 1567 - Pages: 7
a strategy for delaying the entry of generics into the marketplace. It must be understood that once the patent’s exclusivity period of the existing medicine is over, any company may produce that particular chemical entity as long as regulatory requirements are met2. Generic drug companies in India have argued that evergreening has directly threatened their ability to produce drugs at a cost that is accessible to poor people. However, as we now know, the generic drug company can produce the original
Words: 884 - Pages: 4
| Pharmaceutical companies | Research Paper | | Daren Smith | 5/21/2012 | | Abstract There is a lot of discussion about pharmaceutical companies, intellectual property, and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution
Words: 2390 - Pages: 10
